We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Takeda’s £46B Shire Buy Gets Nod From Chinese Regulator

Law360 (September 14, 2018, 5:25 PM EDT) -- Japanese pharmaceutical giant Takeda announced Friday that Chinese regulators have given their “unconditional clearance” for a planned £46 billion ($60 billion) acquisition of Dublin's Shire, the rare disease-focused drugmaker.

The clearance...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.